These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22272271)

  • 1. Evolution of the primate APOBEC3A cytidine deaminase gene and identification of related coding regions.
    Henry M; Terzian C; Peeters M; Wain-Hobson S; Vartanian JP
    PLoS One; 2012; 7(1):e30036. PubMed ID: 22272271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function analyses point to a polynucleotide-accommodating groove essential for APOBEC3A restriction activities.
    Bulliard Y; Narvaiza I; Bertero A; Peddi S; Röhrig UF; Ortiz M; Zoete V; Castro-Díaz N; Turelli P; Telenti A; Michielin O; Weitzman MD; Trono D
    J Virol; 2011 Feb; 85(4):1765-76. PubMed ID: 21123384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms.
    Thielen BK; McNevin JP; McElrath MJ; Hunt BV; Klein KC; Lingappa JR
    J Biol Chem; 2010 Sep; 285(36):27753-66. PubMed ID: 20615867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase.
    Narvaiza I; Linfesty DC; Greener BN; Hakata Y; Pintel DJ; Logue E; Landau NR; Weitzman MD
    PLoS Pathog; 2009 May; 5(5):e1000439. PubMed ID: 19461882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A DNA sequence recognition loop on APOBEC3A controls substrate specificity.
    Logue EC; Bloch N; Dhuey E; Zhang R; Cao P; Herate C; Chauveau L; Hubbard SR; Landau NR
    PLoS One; 2014; 9(5):e97062. PubMed ID: 24827831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity.
    Goila-Gaur R; Khan MA; Miyagi E; Kao S; Strebel K
    Retrovirology; 2007 Aug; 4():61. PubMed ID: 17727729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G.
    Henry M; Guétard D; Suspène R; Rusniok C; Wain-Hobson S; Vartanian JP
    PLoS One; 2009; 4(1):e4277. PubMed ID: 19169351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOBEC3DE Antagonizes Hepatitis B Virus Restriction Factors APOBEC3F and APOBEC3G.
    Bouzidi MS; Caval V; Suspène R; Hallez C; Pineau P; Wain-Hobson S; Vartanian JP
    J Mol Biol; 2016 Aug; 428(17):3514-28. PubMed ID: 27289067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-stranded DNA binding proteins influence APOBEC3A substrate preference.
    Brown AL; Collins CD; Thompson S; Coxon M; Mertz TM; Roberts SA
    Sci Rep; 2021 Oct; 11(1):21008. PubMed ID: 34697369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthologous mammalian APOBEC3A cytidine deaminases hypermutate nuclear DNA.
    Caval V; Suspène R; Vartanian JP; Wain-Hobson S
    Mol Biol Evol; 2014 Feb; 31(2):330-40. PubMed ID: 24162735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the Enzyme-Substrate Properties for APOBEC3A-Mediated RNA Editing.
    Kim K; Shi AB; Kelley K; Chen XS
    J Mol Biol; 2023 Sep; 435(17):168198. PubMed ID: 37442413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid evolution of primate antiviral enzyme APOBEC3G.
    Zhang J; Webb DM
    Hum Mol Genet; 2004 Aug; 13(16):1785-91. PubMed ID: 15198990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOBEC3A is a prominent cytidine deaminase in breast cancer.
    Cortez LM; Brown AL; Dennis MA; Collins CD; Brown AJ; Mitchell D; Mertz TM; Roberts SA
    PLoS Genet; 2019 Dec; 15(12):e1008545. PubMed ID: 31841499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional domain organization of human APOBEC3G.
    Gooch BD; Cullen BR
    Virology; 2008 Sep; 379(1):118-24. PubMed ID: 18639915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H.
    Binka M; Ooms M; Steward M; Simon V
    J Virol; 2012 Jan; 86(1):49-59. PubMed ID: 22013041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOBEC3A Loop 1 Is a Determinant for Single-Stranded DNA Binding and Deamination.
    Ziegler SJ; Hu Y; Devarkar SC; Xiong Y
    Biochemistry; 2019 Sep; 58(37):3838-3847. PubMed ID: 31448897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive evolution of Mus Apobec3 includes retroviral insertion and positive selection at two clusters of residues flanking the substrate groove.
    Sanville B; Dolan MA; Wollenberg K; Yan Y; Martin C; Yeung ML; Strebel K; Buckler-White A; Kozak CA
    PLoS Pathog; 2010 Jul; 6(7):e1000974. PubMed ID: 20617165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cytidine deaminase APOBEC3H restricts HIV-1 replication.
    Dang Y; Siew LM; Wang X; Han Y; Lampen R; Zheng YH
    J Biol Chem; 2008 Apr; 283(17):11606-14. PubMed ID: 18299330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural determinants of human APOBEC3A enzymatic and nucleic acid binding properties.
    Mitra M; Hercík K; Byeon IJ; Ahn J; Hill S; Hinchee-Rodriguez K; Singer D; Byeon CH; Charlton LM; Nam G; Heidecker G; Gronenborn AM; Levin JG
    Nucleic Acids Res; 2014 Jan; 42(2):1095-110. PubMed ID: 24163103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate sequence selectivity of APOBEC3A implicates intra-DNA interactions.
    Silvas TV; Hou S; Myint W; Nalivaika E; Somasundaran M; Kelch BA; Matsuo H; Kurt Yilmaz N; Schiffer CA
    Sci Rep; 2018 May; 8(1):7511. PubMed ID: 29760455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.